MedPath

Assessment of Plasma Lactate in Non-cardiac Surgery Monitoring by Transthoracic Echocardiography

Not Applicable
Conditions
Anesthesia
Registration Number
NCT03103373
Lead Sponsor
Federal University of Juiz de Fora
Brief Summary

The study is a clinical trial, prospective and randomized of 60 patients of both genders, aged between 18 and 80 years, underwent major abdominal surgery. This study aims to compare plasma lactate levels in patients underwent major abdominal surgery (colectomy, gastrectomy, esophagectomy, pancreatectomy, Wertheim Meigs, liver and spleen surgeries) monitored by echocardiography or by conventional techniques (mean arterial pressure , Central venous pressure).

Detailed Description

The study is a clinical trial, prospective and randomized of 60 patients of both genders, aged between 18 and 80 years, underwent major abdominal surgery. This study aims to compare plasma lactate levels in patients underwent major abdominal surgery (colectomy, gastrectomy, esophagectomy, pancreatectomy, Wertheim Meigs, liver and spleen surgeries) monitored by echocardiography or by conventional techniques (mean arterial pressure , Central venous pressure).

The investigators expect to observe a decrease in plasma lactate levels in patients submitted to echocardiographic monitoring when compared to patients submitted to conventional monitoring. In this way, to demonstrate that the routine use of transthoracic echocardiography in patients submitted to large surgery improves the clinical outcomes of these patients and presents a lower hospital cost.

The surgical indication will obey the criteria of the Federal University of Juiz de Fora surgery service, after clinical examination and routine preoperative laboratory tests (complete blood count, complete coagulogram, plasma sodium, potassium Plasma urea and plasma creatinine, blood glucose and liver function test), resting electrocardiogram and chest X-ray. All patients who agree to participate in the study will sign an Informed Consent Term in the preanesthetic evaluation (Appendix 1).

Patients will be computer randomly form by the GraphPad Prisma® program into two groups with 30 patients:

Conventional Group, Transthoracic Echocardiogram Group, All survey data will be noted in the Protocol Data Sheet (Appendix 2). Patients will be anesthetized by the researcher Dr. Marcello Fonseca Salgado Filho, who will also be responsible for performing the intraoperative TTE examination.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria

ages between 18 and 80 years.

  • both genders
  • Large abdominal surgeries
  • Elective surgeries
Exclusion Criteria
  • Emergency surgeries

    • Surgeries of the abdominal aorta
    • Ejection fraction <30%
    • Blood creatinine levels> 2.0mg / dl
    • Glycemia> 200 g / dl
    • Do not agree to participate in the study
    • Bowel obstruction
    • Sepsis
    • Bilirubin> 300 g / dl
    • Alcoholism

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
plasma lactate10 min after the end of the surgery

The plasma lactate will be collected in the arterial line

Secondary Outcome Measures
NameTimeMethod
Assessment heart rate10 min after the end of the surgery

Heart rate

Assessment venus oximetry10 min after the end of the surgery

venus oximetry

Assessment arterial PH10 min after the end of the surgery

arterial PH

Post-operative mortality30 days after surgery

death after surgery

Assessment blood pressure10 min after the end of the surgery

blood pressure

Assessment fluid infusion10 min after the end of the surgery

fluid infusion

Surgery complications30 days after surgery

Assessment fistulae

Infection30 days after surgery

Assessment sepsis

Trial Locations

Locations (1)

federal University of Juiz de Fora

🇧🇷

Juiz de Fora, Minas gerais, Brazil

federal University of Juiz de Fora
🇧🇷Juiz de Fora, Minas gerais, Brazil
Marcello F Salgado Filho, PhD
Contact
+5532999858833
mfonsecasalgado@hotmail.com
Marcello F. Salgado Filho, PhD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.